drugset
Drugs / Allogeneic Bone Marrow-Derived Human Mesenchymal Stromal Cells
last change Feb 2018 re-read 3 minutes ago

Allogeneic Bone Marrow-Derived Human Mesenchymal Stromal Cells

also known as hMSCs
Developed for
adult acute respiratory distress syndrome
Investigated by
Massachusetts General Hospital · Michael A. Matthay · National Heart, Lung, and Blood Institute (NHLBI) · Ohio State University · Stanford University · University of Minnesota
+1 more · University of Pittsburgh

Trials 1

today NCT02097641 · Ph 2
20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02097641 Mar 2014 → Mar 2017 adult acute respiratory distress syndrome Michael A. Matthay Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Allogeneic Bone Marrow-Derived Human Mesenchymal Stromal Cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT02097641 ↗
Known as hMSCs “single dose of Allogeneic Bone Marrow-derived Human Mesenchymal Stromal Cells (hMSCs) infusion” NCT02097641 ↗
Route Intravenous “was administered intravenously over approximately 60-80 minutes” NCT02097641 ↗